Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer

by Parcesepe, Pietro, Giordano, Guido, Laudanna, Carmelo, Febbraro, Antonio, Pancione, Massimo
Published in Gastroenterol Res Pract (2016)

Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis

by Pancione, Massimo, Giordano, Guido, Remo, Andrea, Febbraro, Antonio, Sabatino, Lina, Manfrin, Erminia, Ceccarelli, Michele, Colantuoni, Vittorio
Published 2014

Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports

by Giordano, Guido, Febbraro, Antonio, Quaquarini, Erica, Turletti, Anna, Pedersini, Rebecca, Raffaele, Mimma, Villa, Federica, Rossello, Rosalba
Published in Oncology (2018)

Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept

by Giordano, Guido, Febbraro, Antonio, Venditti, Michele, Campidoglio, Serena, Olivieri, Nunzio, Raieta, Katia, Parcesepe, Pietro, Imbriani, Giusy Carmen, Remo, Andrea, Pancione, Massimo
Published 2014

Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome

by Pancione, Massimo, Sabatino, Lina, Fucci, Alessandra, Carafa, Vincenzo, Nebbioso, Angela, Forte, Nicola, Febbraro, Antonio, Parente, Domenico, Ambrosino, Concetta, Normanno, Nicola, Altucci, Lucia, Colantuoni, Vittorio
Published 2010

Correction: Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome

by Pancione, Massimo, Sabatino, Lina, Fucci, Alessandra, Carafa, Vincenzo, Nebbioso, Angela, Forte, Nicola, Febbraro, Antonio, Parente, Domenico, Ambrosino, Concetta, Normanno, Nicola, Altucci, Lucia, Colantuoni, Vittorio
Published 2011

Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Regi...

by Riccardi, Ferdinando, Colantuoni, Giuseppe, Diana, Anna, Mocerino, Carmela, Cartenì, Giacomo, Lauria, Rossella, Febbraro, Antonio, Nuzzo, Francesco, Addeo, Raffaele, Marano, Ombretta, Incoronato, Pasquale, De Placido, Sabino, Ciardiello, Fortunato, Orditura, Michele
Published in Mol Clin Oncol (2018)

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice

by De Vita, Ferdinando, Ventriglia, Jole, Febbraro, Antonio, Laterza, Maria Maddalena, Fabozzi, Alessio, Savastano, Beatrice, Petrillo, Angelica, Diana, Anna, Giordano, Guido, Troiani, Teresa, Conzo, Giovanni, Galizia, Gennaro, Ciardiello, Fortunato, Orditura, Michele
Published in BMC Cancer (2016)

Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pai...

by Garassino, Marina Chiara, Piva, Sheila, La Verde, Nicla, Spagnoletti, Ilaria, Iorno, Vittorio, Carbone, Claudia, Febbraro, Antonio, Bianchi, Anna, Bramati, Annalisa, Moretti, Anna, Ganzinelli, Monica, Marabese, Mirko, Gentili, Marta, Torri, Valter, Farina, Gabriella
Published 2013

Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting

by Prete, Salvatore Del, Montella, Liliana, Arpino, Grazia, Buono, Giuseppe, Buonerba, Carlo, Dolce, Pasquale, Fiorentino, Olga, Aliberti, Maria, Febbraro, Antonio, Savastano, Clementina, Colantuoni, Giuseppe, Riccardi, Ferdinando, Ruggiero, Angela, Placido, Sabino De, Orditura, Michele
Published in Oncotarget (2020)

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer

by Giordano, Guido, Febbraro, Antonio, Tomaselli, Eugenio, Sarnicola, Maria Lucia, Parcesepe, Pietro, Parente, Domenico, Forte, Nicola, Fabozzi, Alessio, Remo, Andrea, Bonetti, Andrea, Manfrin, Erminia, Ghasemi, Somayehsadat, Ceccarelli, Michele, Cerulo, Luigi, Bazzoni, Flavia, Pancione, Massimo
Published in J Exp Clin Cancer Res (2015)

Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after fir...

by Cardone, Claudia, Martinelli, Erika, Troiani, Teresa, Sforza, Vincenzo, Avallone, Antonio, Nappi, Anna, Montesarchio, Vincenzo, Andreozzi, Francesca, Biglietto, Maria, Calabrese, Filomena, Bordonaro, Roberto, Cordio, Stefano, Bregni, Giacomo, Febbraro, Antonio, Garcia-Carbonero, Rocio, Feliu, Jaime, Cervantes, Andrés, Ciardiello, Fortunato
Published in ESMO Open (2019)

Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience

by Lutrino, Eufemia S., Orlando, Laura, Febbraro, Antonio, Giampaglia, Marianna, Zamagni, Claudio, Schiavone, Paola, Scavelli, Claudio, Dima, Gianluca, Fedele, Palma, Giordano, Guido, Bilancia, Domenico, Quaranta, Anna Maria, Rubino, Daniela, Filippelli, Gianfranco, Fontanella, Caterina, Caliolo, Chiara, Marino, Antonella, Calvani, Nicola, Ferrara, Pasqualinda, Cinieri, Saverio
Published in Tumori (2019)

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian canc...

by Pignata, Sandro, De Placido, Sabino, Biamonte, Rosalbino, Scambia, Giovanni, Di Vagno, Giovanni, Colucci, Giuseppe, Febbraro, Antonio, Marinaccio, Marco, Vernaglia Lombardi, Alessandra, Manzione, Luigi, Cartenì, Giacomo, Nardi, Mario, Danese, Saverio, Valerio, Maria Rosaria, de Matteis, Andrea, Massidda, Bruno, Gasparini, Giampietro, Di Maio, Massimo, Pisano, Carmela, Perrone, Francesco
Published 2006

Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)

by Orditura, Michele, Gravina, Adriano, Riccardi, Ferdinando, Diana, Anna, Mocerino, Carmela, Leopaldi, Luigi, Fabozzi, Alessio, Giordano, Guido, Nettuno, Raffaele, Incoronato, Pasquale, Barzelloni, Maria Luisa, Caputo, Roberta, Pisano, Agata, Grimaldi, Giuseppe, Genua, Geppino, Montesarchio, Vincenzo, Barbato, Enrico, Iodice, Giovanni, Lieto, Eva, Procaccini, Eugenio, Mabilia, Roberto, Febbraro, Antonio, Laurentiis, Michelino De, Ciardiello, Fortunato
Published in ESMO Open (2017)

Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey

by Silvestris, Nicola, Pantano, Francesco, Ibrahim, Toni, Gamucci, Teresa, De Vita, Fernando, Di Palma, Teresa, Pedrazzoli, Paolo, Barni, Sandro, Bernardo, Antonio, Febbraro, Antonio, Satolli, Maria Antonietta, Bertocchi, Paola, Catalano, Vincenzo, Giommoni, Elisa, Comandone, Alessandro, Maiello, Evaristo, Riccardi, Ferdinando, Ferrara, Raimondo, Trogu, Antonio, Berardi, Rossana, Leo, Silvana, Bertolini, Alessandro, Angelini, Francesco, Cinieri, Saverio, Russo, Antonio, Pisconti, Salvatore, Brunetti, Anna Elisabetta, Azzariti, Amalia, Santini, Daniele
Published 2013

Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC

by Perrone, Francesco, Baldassarre, Gustavo, Indraccolo, Stefano, Signoriello, Simona, Chiappetta, Gennaro, Esposito, Franca, Ferrandina, Gabriella, Franco, Renato, Mezzanzanica, Delia, Sonego, Maura, Zulato, Elisabetta, Zannoni, Gian F., Canzonieri, Vincenzo, Scambia, Giovanni, Sorio, Roberto, Savarese, Antonella, Breda, Enrico, Scollo, Paolo, Ferro, Antonella, Tamberi, Stefano, Febbraro, Antonio, Natale, Donato, Maio, Massimo Di, Califano, Daniela, Scognamiglio, Giosuè, Lorusso, Domenica, Canevari, Silvana, Losito, Simona, Gallo, Ciro, Pignata, Sandro
Published in Oncotarget (2016)

Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

by Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Valerio, Maria Rosaria, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Michela, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Alessio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri, Valter
Published in Oncotarget (2018)

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

by Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Ancona, Cristina, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Matilde, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Antonio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri on behalf of The EVA Study Group, Valter
Published in Oncotarget (2018)

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

by Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Valerio, Maria Rosaria, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Matilde, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Alessio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri on behalf of The EVA Study Group, Valter
Published in Oncotarget (2018)